全文获取类型
收费全文 | 2534篇 |
免费 | 270篇 |
国内免费 | 1篇 |
出版年
2023年 | 17篇 |
2022年 | 30篇 |
2021年 | 69篇 |
2020年 | 53篇 |
2019年 | 44篇 |
2018年 | 56篇 |
2017年 | 49篇 |
2016年 | 74篇 |
2015年 | 156篇 |
2014年 | 148篇 |
2013年 | 176篇 |
2012年 | 221篇 |
2011年 | 213篇 |
2010年 | 103篇 |
2009年 | 103篇 |
2008年 | 146篇 |
2007年 | 152篇 |
2006年 | 139篇 |
2005年 | 128篇 |
2004年 | 98篇 |
2003年 | 90篇 |
2002年 | 79篇 |
2001年 | 26篇 |
2000年 | 24篇 |
1999年 | 36篇 |
1998年 | 26篇 |
1997年 | 18篇 |
1996年 | 15篇 |
1995年 | 8篇 |
1994年 | 11篇 |
1992年 | 9篇 |
1991年 | 17篇 |
1990年 | 14篇 |
1989年 | 11篇 |
1988年 | 18篇 |
1987年 | 10篇 |
1985年 | 8篇 |
1984年 | 11篇 |
1983年 | 17篇 |
1982年 | 8篇 |
1981年 | 11篇 |
1978年 | 10篇 |
1977年 | 14篇 |
1974年 | 12篇 |
1973年 | 12篇 |
1972年 | 8篇 |
1971年 | 10篇 |
1970年 | 9篇 |
1969年 | 8篇 |
1968年 | 8篇 |
排序方式: 共有2805条查询结果,搜索用时 15 毫秒
901.
Hawkins O Verma B Lightfoot S Jain R Rawat A McNair S Caseltine S Mojsilovic A Gupta P Neethling F Almanza O Dooley W Hildebrand W Weidanz J 《Journal of immunology (Baltimore, Md. : 1950)》2011,186(11):6607-6616
This report describes a novel HLA/peptide complex with potential prognostic and therapeutic roles for invasive breast cancer. Macrophage migration inhibitory factor (MIF) mediates inflammation and immunity, and MIF overexpression is observed in breast cancer. We hypothesized that the HLA class I of cancerous breast epithelial cells would present MIF-derived peptides. Consistent with this hypothesis, the peptide FLSELTQQL (MIF(19-27)) was eluted from the HLA-A*0201 (HLA-A2) of breast cancer cell lines. We posited that if this MIF(19-27)/HLA-A2 complex was exclusively found in invasive breast cancer, it could be a useful prognostic indicator. To assess the presentation of MIF peptides by the HLA of various cells and tissues, mice were immunized with the MIF(19-27)/HLA-A2 complex. The resulting mAb (RL21A) stained invasive ductal carcinoma (IDC) but not ductal carcinoma in situ, fibroadenoma, or normal breast tissues. RL21A did not stain WBCs (total WBCs) or normal tissues from deceased HLA-A2 donors, substantiating the tumor-specific nature of this MIF/HLA complex. As this MIF/HLA complex appeared specific to the surface of IDC, RL21A was tested as an immunotherapeutic for breast cancer in vitro and in vivo. In vitro, RL21A killed the MDA-MB-231 cell line via complement and induction of apoptosis. In an in vivo orthotopic mouse model, administration of RL21A reduced MDA-MB-231 and BT-20 tumor burden by 5-fold and by >2-fold, respectively. In summary, HLA-presented MIF peptides show promise as prognostic cell surface indicators for IDC and as targets for immunotherapeutic intervention. 相似文献
902.
Verma B Jain R Caseltine S Rennels A Bhattacharya R Markiewski MM Rawat A Neethling F Bickel U Weidanz JA 《Journal of immunology (Baltimore, Md. : 1950)》2011,186(5):3265-3276
mAbs that recognize peptides presented on the cell surface by MHC class I molecules are potential therapeutic agents for cancer therapy. We have previously demonstrated that these Abs, which we termed TCR mimic mAbs (TCRm), reduce tumor growth in models of breast carcinoma. However, mechanisms of TCRm-mediated tumor growth reduction remain largely unknown. In this study, we report that these Abs, in contrast to several mAbs used currently in the clinic, destroy tumor cells independently of immune effector mechanisms such as Ab-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC). We found that TCRm-mediated apoptosis of tumor cells was associated with selective and specific binding of these Abs to peptide/HLA class I complexes, which triggered the activation of JNK and intrinsic caspase pathways. This signaling was accompanied by the release of mitochondrial cytochrome c and apoptosis-inducing factor. TCRm-induced apoptosis in tumor cells was completely inhibited by soluble MHC tetramers loaded with relevant peptide as well as with inhibitors for JNK and caspases. Furthermore, mAbs targeting MHC class I, independent of the peptide bound by HLA, did not stimulate apoptosis, suggesting that the Ab-binding site on the MHC/peptide complex determines cytotoxicity. This study suggests the existence of mechanisms, in addition to ADCC and CDC, through which these therapeutic Abs destroy tumor cells. These mechanisms would appear to be of particular importance in severely immunocompromised patients with advanced neoplastic disease, since immune cell-mediated killing of tumor cells through ADCC and CDC is substantially limited in these individuals. 相似文献
903.
904.
Discovery of genetically distinct hantaviruses in multiple species of shrews (order Soricomorpha, family Soricidae) and moles (family Talpidae) contests the conventional view that rodents (order Rodentia, families Muridae and Cricetidae) are the principal reservoir hosts and suggests that the evolutionary history of hantaviruses is far more complex than previously hypothesized. We now report on Rockport virus (RKPV), a hantavirus identified in archival tissues of the eastern mole (Scalopus aquaticus) collected in Rockport, TX, in 1986. Pairwise comparison of the full-length S, M, and L genomic segments indicated moderately low sequence similarity between RKPV and other soricomorph-borne hantaviruses. Phylogenetic analyses, using maximum-likelihood and Bayesian methods, showed that RKPV shared a most recent common ancestor with cricetid-rodent-borne hantaviruses. Distributed widely across the eastern United States, the fossorial eastern mole is sympatric and syntopic with cricetid rodents known to harbor hantaviruses, raising the possibility of host-switching events in the distant past. Our findings warrant more-detailed investigations on the dynamics of spillover and cross-species transmission of present-day hantaviruses within communities of rodents and moles. 相似文献
905.
906.
Estep RD Messaoudi I O'Connor MA Li H Sprague J Barron A Engelmann F Yen B Powers MF Jones JM Robinson BA Orzechowska BU Manoharan M Legasse A Planer S Wilk J Axthelm MK Wong SW 《Journal of virology》2011,85(18):9527-9542
Monkeypox virus (MPXV) is an orthopoxvirus closely related to variola virus, the causative agent of smallpox. Human MPXV infection results in a disease that is similar to smallpox and can also be fatal. Two clades of MPXV have been identified, with viruses of the central African clade displaying more pathogenic properties than those within the west African clade. The monkeypox inhibitor of complement enzymes (MOPICE), which is not expressed by viruses of the west African clade, has been hypothesized to be a main virulence factor responsible for increased pathogenic properties of central African strains of MPXV. To gain a better understanding of the role of MOPICE during MPXV-mediated disease, we compared the host adaptive immune response and disease severity following intrabronchial infection with MPXV-Zaire (n = 4), or a recombinant MPXV-Zaire (n = 4) lacking expression of MOPICE in rhesus macaques (RM). Data presented here demonstrate that infection of RM with MPXV leads to significant viral replication in the peripheral blood and lungs and results in the induction of a robust and sustained adaptive immune response against the virus. More importantly, we show that the loss of MOPICE expression results in enhanced viral replication in vivo, as well as a dampened adaptive immune response against MPXV. Taken together, these findings suggest that MOPICE modulates the anti-MPXV immune response and that this protein is not the sole virulence factor of the central African clade of MPXV. 相似文献
907.
908.
909.
910.